10,000 participant randomized Phase 2b study will evaluate Gritstone’s self-amplifying mRNA (samRNA) vaccine candidate containing Spike...

Funding will advance pipeline of 17 existing programs and approximately 10 new starts annually Company has raised nearly $700 million in...

INDIANAPOLIS and SOUTH SAN FRANCISCO, Calif., June 20, 2023 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and DICE Therapeutics, Inc....

Data Presented at Late-Breaking Session at Heart Rhythm Society 2023: Paves Way for Premarket Approval Application for Federal Drug...

Multi-year collaboration will facilitate the co-development of optimized therapeutics that bind to challenging targets in ways...

Hypoimmune-modified allogeneic CD19-directed CAR T cells can evade immune detection and kill tumor cells in a novel humanized allogeneic...

Ring raised a total of $86.5 million from new and returning investors, validating its unique approach to creating next-generation...

Proprietary delivery platform, based on endogenous human proteins, offers the potential to enable genetic medicines across a broad range...

RNA Gene Writing™ platform demonstrates clinically relevant levels of in vivo rewriting in the genome of liver cells of non-human...